Acromegaly and Cosmetic Surgery: The Jaw, the Brow, the Nose, the Lips, the Airway, and the Question of Waiting for IGF-1 Control

He is 46 and brought two photographs to the consultation. One is from his wedding, eighteen years ago. The other is from last month. He wants to talk about his jaw, which seems to jut further every year, and his nose, which looks broader than he remembers, and the deep lines that run from his nostrils to the corners of his mouth. He mentions, almost as an afterthought, that his wedding ring had to be resized twice, that he now buys shoes a full size larger than he did in his thirties, that his dentist asked about a new gap between his front teeth, and that his wife has started sleeping in the guest room because of the snoring.

None of those are cosmetic complaints. Together, they describe acromegaly, a hormone disorder that a plastic surgeon has no business treating with a scalpel until an endocrinologist has treated it with something else. This is one of the rare situations in aesthetic medicine where the consultation itself can be the most important thing that happens, because the right answer to "can you fix my jaw" is "not yet, and here is who you need to see first."

For people who have already been diagnosed and treated, the picture is different and more hopeful. Acromegaly and cosmetic surgery can go together well, provided the disease is controlled, the surgeon understands which features will improve on their own, and the anesthesia team respects one of the more challenging airways in elective surgery.

Acromegaly and cosmetic surgery: what the condition is and why the surgeon may notice first

The short answer: acromegaly is a rare condition in which the body makes too much growth hormone in adulthood, almost always because of a benign pituitary tumor, and it causes gradual enlargement of the jaw, brow, nose, lips, tongue, hands, and feet along with serious effects on the heart, airway, and blood sugar.

The pituitary gland sits at the base of the brain and controls several other hormone systems. In more than 95 percent of acromegaly cases, a benign tumor in that gland, called a pituitary adenoma, releases excess growth hormone. Growth hormone drives the liver to produce insulin-like growth factor 1 (IGF-1), and it is IGF-1 that does most of the visible work. Before the growth plates close in childhood, the same excess causes gigantism. After they close, bones cannot grow longer, so they grow thicker and wider instead, and soft tissues swell.

Acromegaly is uncommon, with estimates generally in the range of several to around fourteen cases per 100,000 people. Its defining problem is speed, or rather the lack of it. The changes are so gradual that the person, their family, and their doctors often fail to notice them. The average delay between the first changes and the diagnosis is commonly cited as five to ten years. By then, many patients have developed high blood pressure, diabetes, sleep apnea, or heart enlargement.

The features that bring people to a plastic surgeon are usually these:

• A protruding lower jaw (mandibular prognathism), often with a new underbite and widening gaps between the lower teeth.
• A heavy brow, with prominent ridges above the eyes and frontal bossing of the forehead.
• A larger, broader nose, with thicker skin and wider nostrils.
• Fuller, thicker lips and an enlarged tongue (macroglossia).
• Deep facial folds, including heavy nasolabial lines and a coarse, thickened look to the skin.
• Thick, oily skin, heavy sweating, and an increase in skin tags.
• Larger hands and feet, which people notice as rings and shoes that no longer fit.

Several of these overlap with ordinary aging or ordinary anatomy, which is exactly why the diagnosis gets missed. A strong jaw is not acromegaly. A jaw that has changed in adulthood, together with a growing shoe size and a new gap in the teeth, deserves a blood test. Endocrine Society guidance recommends measuring IGF-1 in people with the typical features, and when IGF-1 is high or borderline, an oral glucose tolerance test checks whether growth hormone fails to suppress the way it should. An MRI of the pituitary then looks for the tumor.

Dentists, orthodontists, and plastic surgeons see faces closely and repeatedly, and the medical literature includes patients whose acromegaly was first suspected in a dental chair or a cosmetic consultation. A surgeon who compares old photographs, asks about rings and shoes, and asks about headaches or changes in peripheral vision is doing real medicine. A surgeon who simply books a jawline contouring procedure or reaches for filler is not. The same logic appears in the piece on swollen parotid glands and a wide jaw: when a face changes shape in adulthood, the first question is why.

Waiting for control: IGF-1, what shrinks, and what stays

The short answer: after acromegaly is controlled, the soft tissue swelling of the lips, nose, tongue, and skin often improves noticeably over months, but the bone changes in the jaw and brow do not reverse, so cosmetic surgery should wait until IGF-1 has been normal and stable long enough for the face to settle.

Treatment usually starts with transsphenoidal surgery, in which a neurosurgeon removes the pituitary tumor through the nose or upper lip without an external scar. When surgery does not fully control the disease, or is not possible, the options include medications called somatostatin receptor ligands (octreotide, lanreotide, and pasireotide), a growth hormone receptor blocker called pegvisomant, the dopamine agonist cabergoline in some cases, and radiation therapy. Control is defined mainly by a normal IGF-1 level for the person's age and sex, along with suppressed growth hormone.

Control matters for two separate reasons. The first is safety: uncontrolled acromegaly carries real cardiovascular and metabolic risk, and the evidence suggests that once the disease is controlled, much of the excess mortality associated with it falls toward that of the general population. The second is the face itself. When growth hormone falls, fluid and soft tissue swelling recede. People often report that their rings fit better, their lips look thinner, their skin is less oily, and their sweating eases, sometimes within weeks to months.

What does not change is bone. The thickened brow ridge, the enlarged frontal sinus behind it, the lengthened and widened lower jaw, and the spread of the teeth stay where acromegaly put them. A face that has been reshaped by years of excess growth hormone will be partly softened by treatment and partly not.

That split is the whole reason to wait. Operate on the lips and nose while the disease is still active, and the soft tissue will keep changing underneath the result. Operate before treatment has finished softening the face, and a patient may pay for a lip reduction that a few more months of normal IGF-1 would have accomplished partly on its own. Many endocrinologists and surgeons prefer to see stable biochemical control for a meaningful stretch, often a year or so, before planning definitive facial surgery. There is no universal number, and the endocrinologist's judgment about stability should carry the most weight.

"Treatment shrinks what acromegaly swelled. It does not shrink what acromegaly built. A good surgical plan waits to see the difference."

Recurrence is the other reason for patience. Acromegaly can return after apparently successful pituitary surgery, and some patients remain on long-term medication. Facial surgery should be planned with the endocrinologist in the loop, not after a single good lab result.

There is also a hormonal complication from treatment that matters directly in the operating room. Pituitary surgery and radiation can damage the normal parts of the gland, leading to hypopituitarism. If the gland no longer makes enough of the hormone that drives cortisol production, the patient needs daily steroid replacement and extra stress-dose steroids for surgery, for the same reasons described in the piece on Addison's disease and cosmetic surgery. Low thyroid hormone, low testosterone or estrogen, and diabetes insipidus (a problem with water balance) can also follow. Every one of these should be known and managed before an elective operation.

The jaw, the brow, the nose, the lips, and the tongue

The short answer: the bony changes of acromegaly are corrected with orthognathic jaw surgery, chin reduction, and brow or forehead contouring, while the soft tissue changes are addressed with lip reduction, rhinoplasty, and sometimes tongue reduction, usually staged and always after the disease is controlled.

The jaw and bite. Acromegaly often pushes the lower jaw forward into a Class III bite, with the lower teeth in front of the upper teeth and gaps opening between them. Filler, implants, or contouring cannot fix that, because the problem is how the jaws meet. The standard correction is orthognathic surgery, often a lower jaw setback and sometimes surgery on both jaws, coordinated with orthodontics before and after. The piece on orthognathic jaw surgery versus jawline procedures explains why a bite problem needs a bite operation, and the piece on braces, aligners, and facial cosmetic surgery timing covers the sequencing with orthodontic work. Published case series of orthognathic surgery in treated acromegaly report good functional and aesthetic results when the disease is controlled.

The tongue. An enlarged tongue matters more than people expect. After a jaw setback, there is less room in the mouth, and a large tongue can push the teeth and jaw back toward the old position, worsen the airway, and contribute to relapse. Some surgeons perform a partial tongue reduction (reduction glossectomy) as part of the plan when the tongue remains enlarged after treatment. This is a decision for an experienced maxillofacial team, not an add-on.

The chin. When the chin itself has lengthened or projects too far even after the bite is corrected, a sliding genioplasty or burring can reduce it. The piece on chin reduction surgery explains the soft tissue pitfalls, including the witch's chin deformity that can follow simple burring, and the piece on chin augmentation and facial harmony explains why chin size is always judged against the nose and lips.

The brow and forehead. Frontal bossing in acromegaly is partly bone and partly an enlarged frontal sinus, an air space behind the brow. When the bone in front of the sinus is thick, a surgeon can burr it down. When the sinus is large and the front wall is thin, burring would break into it, and the correction requires removing the front wall, reshaping it, and setting it back, the same brow-bone setback technique used in facial feminization surgery. A CT scan is needed to know which approach is safe. Patients who also want a shorter forehead should read the piece on hairline lowering, since the incisions can sometimes be shared.

The nose. A nose enlarged by acromegaly often has thick skin, and thick skin limits how much definition any rhinoplasty can create. Treatment usually thins the skin somewhat, which is another argument for waiting. Many people with acromegaly also have nasal airway problems from swollen lining and turbinates, so a combined approach like the one described in the piece on functional rhinoplasty is common. For men, the goals discussed in the piece on male rhinoplasty apply: reduce the size without producing a nose that looks borrowed from a smaller face.

The lips. Lips are among the features most likely to improve after treatment, so they are among the last to operate on. When they stay thick, a lip reduction removes a strip of tissue from the inside of the lip with the scar hidden behind the wet line, as described in the piece on lip reduction surgery.

Staging. Doing everything at once can mean a very long anesthetic in a patient with a hard airway. Many teams stage the work, often with jaw and bite correction first because it changes the foundation everything else sits on, and soft tissue refinements later.

The airway, sleep apnea, the heart, and blood sugar

The short answer: acromegaly enlarges the tongue, the tissues of the throat, and sometimes the larynx itself, which can make breathing tubes difficult to place, and it frequently causes sleep apnea, high blood pressure, heart enlargement, and diabetes, all of which need assessment before elective surgery.

Anesthesiologists consider acromegaly one of the classic causes of a difficult airway. A large tongue, thick lips, an enlarged epiglottis, swollen tissue around the vocal cords, and narrowing below the vocal cords can make both mask ventilation and intubation difficult. Some patients need a smaller breathing tube than their size would suggest, and some need the tube placed while awake using a flexible scope. None of this means surgery is unsafe. It means the operation belongs in a facility where an anesthesiologist has reviewed the airway in advance and has the equipment to manage it, not in an office suite with minimal backup. The piece on anesthesia choice and the operative plan is worth reading with this in mind.

Sleep apnea. Obstructive sleep apnea is common in acromegaly, with many studies finding it in well over half of patients at diagnosis, and it does not always resolve with treatment. Untreated sleep apnea raises the risk of breathing problems after anesthesia, especially with opioid pain medication. A sleep study before surgery and a plan for CPAP afterward are standard expectations, as described in the piece on sleep apnea before cosmetic surgery.

The heart. Long-standing growth hormone excess can thicken the heart muscle, a condition called acromegalic cardiomyopathy, and can cause heart rhythm problems and valve disease. High blood pressure is common. An echocardiogram and an ECG are reasonable before major elective surgery, particularly in patients with a long delay before diagnosis. The piece on high blood pressure before cosmetic surgery covers what targets surgeons look for and which medications to continue.

Blood sugar. Growth hormone opposes insulin, so diabetes and prediabetes are common in acromegaly. Some of the treatments matter here too: pasireotide in particular can raise blood sugar, and other somatostatin receptor ligands can shift glucose in either direction. Poorly controlled blood sugar slows wound healing and raises infection risk, which is why the piece on blood sugar and cosmetic surgery matters to this group. Skin darkening in the neck and armpits, a marker of insulin resistance discussed in the piece on acanthosis nigricans, is also seen in acromegaly.

The rest of the workup. Somatostatin receptor ligands can cause gallstones, which is worth knowing if abdominal pain appears after surgery. Guidelines also recommend a screening colonoscopy at diagnosis because colon polyps are more common, and thyroid nodules occur more often. None of these is a reason to delay a facial operation on its own, but a surgeon who asks about them is reading the whole chart.

Skin, sweat, hands, and the growth hormone sold as anti-aging

The short answer: many of the skin complaints of acromegaly, including oiliness, heavy sweating, and skin tags, improve with treatment and respond to ordinary dermatologic care, while growth hormone marketed for anti-aging can itself produce acromegaly-like changes and has no FDA approval for that use.

Sweating. Excessive sweating is one of the most common symptoms of active acromegaly and often eases with control. When it persists, the same botulinum toxin injections used for ordinary underarm and palm sweating work here, as covered in the piece on Botox for hyperhidrosis.

Skin tags and thick skin. Skin tags are more common in acromegaly and can be removed simply, as described in the piece on skin tags and benign growth removal. Thick, oily skin tends to improve with treatment. Deep nasolabial folds often soften partly as the swelling recedes, so filler placed before control may end up looking overdone once the face settles.

The hands. Enlarged hands do not shrink back to their old proportions, though swollen soft tissue improves. Carpal tunnel syndrome is common in active acromegaly because the swollen tissue compresses the median nerve, and it often improves with treatment. Anyone considering hand rejuvenation should know the limits laid out in the piece on hand rejuvenation: fillers and lasers improve the surface, not the size of the bones.

Masseter and jaw width. People with a wide lower face from acromegaly sometimes ask about masseter Botox. It can slim an enlarged muscle, but it cannot narrow bone, and the piece on masseter Botox explains how to tell the difference in a mirror.

Growth hormone sold as anti-aging. There is an irony worth stating plainly. Growth hormone and growth hormone stimulating peptides are marketed by some clinics as anti-aging treatments for skin, energy, and body composition. The FDA has not approved growth hormone for anti-aging, and prolonged exposure to excess growth hormone is, by definition, the mechanism of acromegaly. Reported risks of supraphysiologic dosing include joint pain, fluid retention, carpal tunnel symptoms, and worse glucose control. Anyone weighing those injections should understand that the condition in this article is what a sustained overdose of the hormone looks like.

The emotional side. Many people with acromegaly describe years of watching their own face change without knowing why, sometimes with comments from strangers or relatives along the way. Wanting some of the old face back is a reasonable goal, and so is accepting that a perfect return is not possible. The piece on emotional recovery after plastic surgery is worth reading before the operation. If a person's distress feels out of proportion to the changes others can see, the screening described in the piece on body dysmorphic disorder deserves a conversation too.

The honest summary

Acromegaly is rare, slow, and very often missed, and the plastic surgeon's office is one of the places it can be caught. A jaw, brow, or nose that has changed in adulthood, especially alongside larger rings and shoes, new gaps in the teeth, heavy sweating, and loud snoring, is a reason for an IGF-1 test before it is a reason for a procedure.

For people who have been diagnosed and treated, cosmetic surgery can help a great deal. The soft tissue changes of the lips, nose, tongue, and skin often improve on their own after the disease is controlled, which is why waiting for stable IGF-1 control comes first. The bone changes of the jaw and brow do not reverse, and correcting them means orthognathic surgery, chin reduction, and brow contouring planned with a CT scan and, for the bite, an orthodontist.

The airway, sleep apnea, heart, blood sugar, and any pituitary hormone deficiencies left by treatment decide where and how the operation should happen. A surgeon who wants to talk to your endocrinologist before quoting a price is the surgeon to choose. If the first one you see does not, it is worth a second consultation.